Paying for neurodiversity diagnoses

Mail on Sunday article highlights the cost and profitability of private ADHD clinics. As I said in a previous post, neurodiversity has become an industry, often more motivated by profit than patient interest. Packaging our everyday problems as neurodiverse conditions, that can be diagnosed and treated, may well be creating more problems than it is worth (see eg. another previous post). Discouraging self-responsibility may well not really be helping to resolve underlying difficulties (see eg. yet another previous post). 

As the government independent review into mental health conditions, ADHD and autism has found (see last post), diagnosis alone is insufficient for assessing the need for personal adaptations in educational and workplace settings. Exposing how ADHD diagnostic services may be organised more for their own interests than those of patients reinforces the need to challenge widespread misleading myths about neurodiversity (see eg. another previous post).